Breast cancer epidemiology, prevention, and early detection

被引:38
作者
Brewster, A
Helzlsouer, K
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD USA
关键词
D O I
10.1097/00001622-200111000-00002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer remains a worldwide public health concern despite the fact that mortality rates have been declining in some countries as a result of improvements in adjuvant therapy and screening for breast cancer. In the prevention arena, advances in our understanding of the effects of tamoxifen have led to the investigations of newer agents that may provide extended options for breast cancer prevention in high-risk women. For women who are carriers of a mutation in the breast cancer susceptibility genes BRCA1 or BRCA2, prophylactic oophorectomy and bilateral mastectomy have emerged as preventative surgical options that can significantly impact breast cancer risk. In addition, the identification of potentially modifiable risk factors for breast cancer such as dietary folate intake, alcohol consumption, physical activity, and certain anthropometric factors provides opportunities for intervening in breast cancer prevention both among women at average and high risk. The challenge remains in overcoming the limitations of mammography and clinical breast examination by developing and evaluating new technologies for breast cancer screening such as digital mammogram and breast magnetic resonance imaging. Curr Opin Oncol 2001, 13:420-425 (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:420 / 425
页数:6
相关论文
共 63 条
  • [31] Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic
    Martin, AM
    Blackwood, MA
    Antin-Ozerkis, D
    Shih, HA
    Calzone, K
    Colligon, TA
    Seal, S
    Collins, N
    Stratton, MR
    Weber, BL
    Nathanson, KL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) : 2247 - 2253
  • [32] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer, H
    van Geel, B
    van Putten, WLJ
    Henzen-Logmans, SC
    Seynaeve, C
    Menke-Pluymers, MBE
    Bartels, CCM
    Verhoog, LC
    van den Ouweland, AMW
    Niermeijer, MF
    Brekelmans, CTM
    Klijn, JGM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 159 - 164
  • [33] Global breast cancer mortality statistics
    Mettlin, C
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (03) : 138 - 144
  • [34] Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years
    Miller, AB
    To, T
    Baines, CJ
    Wall, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18): : 1490 - 1499
  • [35] Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt
  • [36] 827::AID-IJC6&gt
  • [37] 3.0.CO
  • [38] 2-P
  • [39] Powles T, 1998, LANCET, V352, P98
  • [40] Pukkala E, 1993, Eur J Cancer Prev, V2, P369, DOI 10.1097/00008469-199309000-00002